Wang, Lifei <br/><br/>
Regulation of cellular growth, apoptosis, and Akt activity in human U251 glioma cells by a combination of cisplatin with CRM197.  [electronic resource] 

 -  Anti-cancer drugs  Jan 2012 
 - 81-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0b013e32834b9b72  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstadienes--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Bacterial Proteins--administration & dosage<br/>Cell Line, Tumor<br/>Central Nervous System Neoplasms--drug therapy<br/>Chromones--pharmacology<br/>Cisplatin--administration & dosage<br/>Glioma--drug therapy<br/>Growth Inhibitors--pharmacology<br/>Humans<br/>Morpholines--pharmacology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Wortmannin